The popularity of Sildenafil initially sparked a surge for major pharmaceutical companies, nevertheless recent changes present a uncertain picture for shareholders. Generic versions are eating into earnings, and https://joshxaqw035563.bloguerosa.com/39859112/viagra-and-the-pharmaceutical-industry-a-precarious-investment